REBECCA RATHBURN: Open Payments
NPI 1881271963 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 6 payments from 4 companies in 2025. Trend: 2023 $1,871 · 2024 $9,015 · 2025 $907
Food & beverage: $590Education: $317
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $392 |
| Madrigal Pharmaceuticals | 2 | $271 |
| Novo Nordisk Inc | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
Products named: Lenvima, REZDIFFRA, Wegovy.
Industry payments across MA — which companies pay providers there.
